Semax is a synthetic peptide fragment of the adrenocorticotropic hormone (ACTH) developed in Russia. It is primarily known for its nootropic and neuroprotective effects, believed to work by increasing brain-derived neurotrophic factor (BDNF) and modulating neurotransmitter systems. Its relevance to healthspan is speculative, focusing on the potential preservation of cognitive function and neuronal health against age-related decline, though robust evidence in this context is lacking.
Verdict
Experimental nootropic with unproven relevance to core longevity pathways.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
High
EVIDENCE GRADE
D
MONTHLY COST
$40 - $80
Protocol
- Administer 200-600 mcg intranasally daily for 10-14 days, followed by a multi-week washout period.
Flags
- Sourced as an unregulated research chemical in many countries, raising purity/potency concerns.
- Long-term effects on the HPA (Hypothalamic-Pituitary-Adrenal) axis are not well-studied.
- Potential for anxiety, irritability, or hair shedding in sensitive individuals.
- Lacks robust, long-term safety data for use in healthy individuals.